Help

1. Priprema
2. Uključite
3. Prepoznavanje + procjena
4. Plan mjera
5. Consultancy
6. Završni dokumenti
7. Status
8. Settings

Toggle tree
Unlocked Share 0%

You've completed 0% of the risk assessment. When you've completed 85% of the risk assessment, you will be eligible for a certificate.

With this certificate, you can apply for a reduction on your company's insurance rates. Learn more about the benefits…

View the Status screen for more details.

More

#

Saznajte više o ovom alatu…

Unesite naslov svoje procjene rizika Once you have started an OiRA tool session, you will be able to stop before the end. You can restart it again at a later date by selecting the title of the OiRA tool session. You can save more than one session, provided you have given them different title names. Please remember your e-mail address, password and the title that you have given the OiRA tool session. By clicking on the Logout button, you are logged out actively. You are also logged out if you close your Browser. For security reasons it is better to actively log out.
Send me occasional e-mails with news about the tool 'Private security'

This tool deserves to be known by the world! Share it via Twitter, Facebook or E-mail.

- Twitter
- Facebook
- E-mail

Last edited by Hans Mittelmaier on 7 November 2022.

#

Scroll towards the end.

- #### Liz Baker

  started assessment | 20 February 2016 — 12:15

- #### Liz Baker

  locked | 1 March 2016 — 16:40

- #### Liz Baker

  unlocked | 1 March 2016 — 16:40

- #### Liz Baker

  sent documents to cornelis@cornae.com | 1 March 2016 — 16:40

- #### Mario Minstreel

  archived | 3 March 2016 — 10:12

Scroll to top
Back

## portlet-so-and-so.html

Više

Help

- Splash and Shine Cleaners Last saved 19 days ago based on EU Cleaning More
- Commercial Guardinng, Leicester Last saved 2 months ago based on Private Security EU More
- Private Security, Grafton Street Last saved 2 months ago based on Private Security EU More
- Office operations in times of COVID-19 Last saved 4 months ago based on COVID-19 More